Development of a gene transfer-based treatment for radiation-induced salivary hypofunction.

[1]  P. Levendag,et al.  Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. , 2009, International journal of radiation oncology, biology, physics.

[2]  A. Garden,et al.  Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Jemal,et al.  Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.

[4]  N. Slevin,et al.  Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy. , 2009, European journal of cancer.

[5]  Miao-Fen Chen,et al.  Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. , 2009, Oral oncology.

[6]  Johannes A Langendijk,et al.  Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. , 2009, International journal of radiation oncology, biology, physics.

[7]  K. Sultanem,et al.  Phase III randomized study: Oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation‐induced xerostomia , 2009, Head & neck.

[8]  N. Aaronson,et al.  Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Chiorini,et al.  Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. , 2007, Human gene therapy.

[10]  J. Chiorini,et al.  Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. , 2006, Human gene therapy.

[11]  James B. Mitchell,et al.  Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. , 2006, Biochimica et biophysica acta.

[12]  M. Haskins,et al.  Large animal models and gene therapy , 2006, European Journal of Human Genetics.

[13]  B. Baum,et al.  Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. , 2005, International journal of radiation oncology, biology, physics.

[14]  B. Baum,et al.  Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  Jianghuai Wang,et al.  Salivary glands: novel target sites for gene therapeutics. , 2004, Trends in molecular medicine.

[16]  I. Bossis,et al.  Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Baum,et al.  Developing a convenient large animal model for gene transfer to salivary glands in vivo , 2004, The journal of gene medicine.

[18]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[19]  D. Brizel,et al.  Does amifostine have a role in chemoradiation treatment? , 2003, The Lancet. Oncology.

[20]  A. Vissink,et al.  Prevention and treatment of the consequences of head and neck radiotherapy. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[21]  B. Baum,et al.  The use of gene transfer for the protection and repair of salivary glands. , 2002, Oral diseases.

[22]  J. Ship,et al.  Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[23]  C. Delporte,et al.  Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates , 1999, Cancer Gene Therapy.

[24]  R. Kotin,et al.  Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. , 1998, Human gene therapy.

[25]  C. Delporte,et al.  Relationship between adenovirus-mediated aquaporin 1 expression and fluid movement across epithelial cells. , 1998, Biochemical and biophysical research communications.

[26]  S. Yu,et al.  Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. , 1998, Human gene therapy.

[27]  P. Agre,et al.  Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[29]  B. Baum,et al.  Principles of Saliva Secretion , 1993, Annals of the New York Academy of Sciences.

[30]  P. Agre,et al.  Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. Fox,et al.  Subjective reports of xerostomia and objective measures of salivary gland performance. , 1987, Journal of the American Dental Association.

[32]  A. Glucksmann,et al.  Injury and repair following irradiation of salivary glands in male rats. , 1959, The British journal of radiology.

[33]  A. D. Caballero,et al.  Oral sequelae of head and neck radiotherapy , 2011 .

[34]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[35]  G. Illei,et al.  Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. , 2009, Handbook of experimental pharmacology.

[36]  R. Crystal,et al.  Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. , 2002, Human gene therapy.

[37]  B. Baum,et al.  Gene transfer to salivary glands. , 2002, International review of cytology.

[38]  R. Crystal,et al.  Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. , 2002, Human gene therapy.

[39]  U. Brunk,et al.  Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland , 1984, Virchows Archiv. B, Cell pathology including molecular pathology.